Tariffs
The Trump administration April 2 announced the implementation of a new tariff plan that will impose a 10% universal tariff on imported goods from all countries beginning April 5.
H-ISAC TLP Green Report on Trade Impacts of Proposed Tariffs on the EU Pharmaceutical Sector.
President Trump Feb. 13 signed a presidential memorandum ordering the development of a comprehensive plan for “restoring fairness in U.S. trade relationships and countering non-reciprocal trading arrangements.”
The Trump administration yesterday announced it issued executive orders authorizing 25% tariffs on all steel and aluminum imports. Importantly, both steel and aluminum are used broadly for medical devices such as surgical instruments, prosthetics, implants, crutches, wheelchairs, plates and screws…
The AHA late Feb. 4 told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
The AHA late yesterday told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
The White House issued Feb. 1 executive orders that impose tariffs on products from Canada, Mexico and China.
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China.
The AHA sent a letter June 28 to the U.S. Trade Representative responding to a proposed increase in Section 301 tariffs for goods produced in China, which would include health care products.